Form 13-F position report

NEXTCURE INC COM (DE)

Reported by MORGAN STANLEY

NXTC CUSIP 65343E108 Manager CIK 0000895421

Reported 301 shares, down 118,038 (99.7%) from the prior quarter.

Reported value -99.7%; share count -99.7% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 301 Quarter-end amount reported
Reported value $542 Fair value at quarter end
Consecutive quarters held 17 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 437000
2022-03-31 341000
2022-06-30 212000
2022-09-30 116000
2022-12-31 42806
2023-03-31 175142
2023-06-30 542
2023-09-30 0
2023-12-31 92143
2024-03-31 897035
2024-06-30 2
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for NEXTCURE INC COM (DE) held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -1 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 1 -402,257 (-100.0%) < 0.01% $2 2024-08-14
Q1 2024 Added 402,258 +321,431 (397.7%) < 0.01% $897,035 2024-05-15
Q4 2023 New 80,827 +80,827 (0.0%) < 0.01% $92,143 2024-02-13
Q3 2023 Reduced 0 -301 (-100.0%) 0 $0 2023-11-15
Q2 2023 Reduced 301 -118,038 (-99.7%) < 0.01% $542 2023-08-14
Q1 2023 Added 118,339 +87,980 (289.8%) < 0.01% $175,142 2023-05-15
Q4 2022 Reduced 30,359 -11,752 (-27.9%) < 0.01% $42,806 2023-02-14
Q3 2022 Reduced 42,111 -2,946 (-6.5%) < 0.01% $116,000 2022-11-14
Q2 2022 Reduced 45,057 -25,083 (-35.8%) < 0.01% $212,000 2022-08-15
Q1 2022 Reduced 70,140 -2,664 (-3.7%) < 0.01% $341,000 2022-05-13
Q4 2021 Reduced 72,804 -82,593 (-53.1%) < 0.01% $437,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

48 managers reported NEXTCURE INC COM (DE) for Q2 2023.

Managers reporting NEXTCURE INC COM (DE) in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ORBIMED ADVISORS LLC Unchanged 2,711,013 0 0.09% $4,879,823 17 qtrs
Sofinnova Investments Inc Unchanged 2,671,856 0 0.32% $4,809,341 17 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 1,409,055 -44,965 < 0.01% $2,536,299 17 qtrs
BlackRock Inc Added 925,320 +897 < 0.01% $1,665,577 17 qtrs
VANGUARD GROUP INC Unchanged 908,473 0 < 0.01% $1,635,252 17 qtrs
Long Focus Capital Management LLC Unchanged 556,105 0 0.05% $1,000,989 7 qtrs
ACADIAN ASSET MANAGEMENT LLC Unchanged 488,440 0 < 0.01% $878,000 10 qtrs
TANG CAPITAL MANAGEMENT LLC Unchanged 400,000 0 0.11% $720,000 2 qtrs
CITADEL ADVISORS LLC Reduced 393,263 -86,584 < 0.01% $707,873 17 qtrs
FEDERATED HERMES INC Reduced 366,949 -21,620 < 0.01% $660,508 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1
Shared
0
None
300

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.